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Abstract 
Rationale: Under some conditions stress, rather than directly triggering 
cocaine seeking, potentiates reinstatement to other stimuli, including a sub-
threshold cocaine dose. The mechanisms responsible for stress-potentiated 
reinstatement are not well-defined. Endocannabinoid signaling is increased by 
stress and regulates synaptic transmission in brain regions implicated in 
motivated behavior. 
Objectives: To test the hypothesis that cannabinoid receptor 1 (CB1R) 
signaling is required for stress-potentiated reinstatement of cocaine seeking 
in rats. 
Methods: Following i.v. cocaine self-administration (2 hr access/day) and 
extinction in male rats, footshock stress alone does not reinstate cocaine 
seeking, but reinstatement is observed when footshock is followed by an 
injection of an otherwise subthreshold dose of cocaine (2.5 mg/kg, i.p.). 
CB1R involvement was tested by systemic administration of the CB1R 
antagonist AM251 (0, 1, or 3 mg/kg, i.p.) prior to testing for stress-
potentiated reinstatement. 
Results: Stress-potentiated reinstatement was blocked by both 1 and 3 
mg/kg AM251. By contrast, AM251 only attenuated food-reinforced lever 
pressing at the higher (i.e., 3 mg/kg) dose and did not affect locomotor 
activity at either dose tested. Neither high-dose cocaine-primed reinstatement 
(10 mg/kg, i.p.) nor footshock stress-triggered reinstatement following long-
access cocaine self-administration (6 hr access/day) were affected by AM251 
pretreatment. Footshock stress increased concentrations of both 
endocannabinoids, N-arachidonylethanolamine and 2-arachidonoylglycerol, in 
regions of the prefrontal cortex. 
Conclusions: These findings demonstrate that footshock stress increases 
prefrontal cortical endocannabinoids and stress-potentiated reinstatement is 
CB1R-dependent, suggesting that CB1R is a potential therapeutic target for 
relapse prevention, particularly in individuals whose cocaine use is stress-
related. 
 
Keywords: addiction, cocaine, stress, reinstatement, relapse, 
endocannabinoid, self-administration 
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Introduction 
The sudden and often unpredictable relapse to drug use that can 
emerge even after prolonged periods of drug abstinence is a major 
obstacle to the effective long-term management of substance abuse. 
The ability to prevent relapse has been hindered by an imprecise and 
incomplete understanding of situations that lead to the re-emergence 
of drug-seeking behavior and the underlying neurobiological 
processes. 
Stress plays a particularly problematic role in drug relapse 
(McReynolds et al. 2014; Shaham et al. 2000) as it is prevalent and 
unavoidable in daily life. While it is evident that stress contributes to 
relapse, the manner in which it does so appears to be more complex 
than simply triggering use. For example, while clinical laboratory 
studies have found that stress imagery can trigger craving (Sinha 
2009), self-reports by addicts regarding the role of stress in their drug 
use are suggestive of a less direct relationship between stress and 
relapse (Furnari et al. 2015; Preston and Epstein 2011). Consistent 
with this more nuanced role for stress, others have reported that 
stress may interact with other relapse triggers to promote drug use 
(Coffey et al. 2002; De La Garza et al. 2009; Duncan et al. 2007). 
These reports parallel findings from preclinical studies showing that 
acute stressors can potentiate reinstatement induced by cocaine-
related cues in rats (Buffalari and See 2009; Feltenstein and See 
2006). 
Previous studies from our laboratory have demonstrated that 
the ability of intermittent electric footshock to reinstate extinguished 
cocaine seeking in rats can vary depending on the prior history of 
cocaine use. We have identified conditions under which rats with a 
history of extended access cocaine self-administration (14 × 6 
hrs/day) show robust footshock-triggered reinstatement of cocaine 
seeking following extinction, while rats that have a history of more 
limited daily access (14 × 2 hrs/day) do not (Mantsch et al. 2008a). 
However, although footshock stress does not directly reinstate cocaine 
seeking following self-administration under these short-access 
conditions, it can amplify the effects of an otherwise sub-threshold 
priming injection of cocaine (2.5 mg/kg; Graf et al. 2013), thereby 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg 
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin 
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Springer-Verlag Berlin Heidelberg. 
4 
 
potentiating reinstatement. We have proposed that this potentiating 
effect of footshock stress reflects its role in many drug users in whom 
stress appears to “set the stage” for cocaine use. In contrast to the 
relapse-triggering effects of stress, which have been extensively 
studied, relatively little is known about the neurobiological 
mechanisms that underlie these stage-setting effects of stress. 
We recently reported that stress-potentiated reinstatement, 
unlike stress-triggered reinstatement (Mantsch et al. 2008a), is 
corticosterone-dependent, and that elevated corticosterone is sufficient 
to reproduce the potentiating effect of stress (Graf et al. 2013). 
Moreover, we found that one corticosterone-dependent mechanism 
through which stress potentiates cocaine-induced reinstatement 
involves reduced dopamine clearance in the nucleus accumbens by the 
glucocorticoid-sensitive organic cation transporter 3 (OCT3; Graf et al. 
2013). Endocannabinoid (eCB) signaling represents a second 
corticosterone-dependent mechanism through which stress could 
potentiate cocaine-induced reinstatement. Both stress and 
corticosterone increase eCB levels in brain regions that have been 
implicated in drug-seeking behavior, most notably the prefrontal 
cortex (PFC) and nucleus accumbens (NAc; Hill et al. 2011; 
Rademacher et al. 2008). In the brain, the CB1Rs are thought to 
represent the primary targets for eCB signaling (Devane et al. 1988; 
Egertova et al. 1998; Herkenham et al. 1991; Howlett et al. 2002; 
Pertwee 1997; Pertwee and Ross 2002), although CB2R-mediated 
effects have been reported (Brusco et al. 2008; Onaivi 2011; Onaivi et 
al. 2006). As CB1Rs have been proposed to play a critical role in both 
drug addiction (Sidhpura and Parsons 2011) and adaptation to stress 
(Hill et al. 2010), we hypothesize that stress potentiation of cocaine-
induced reinstatement requires eCB signaling through CB1Rs. In the 
present study we test this hypothesis by assessing the effects of the 
CB1R antagonist, AM251, on stress-potentiated reinstatement. 
Methods 
Subjects 
Male Sprague-Dawley rats (275–300 g at arrival), obtained from 
Harlan Laboratories, were individually housed in a humidity- and 
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temperature-controlled AAALAC-accredited facility with food and water 
available ad libitum. Rats were maintained on a 12h/12h reverse 
light/dark cycle (0700–1900 lights off) and all behavioral procedures 
were conducted during the dark phase of the light cycle. All 
experimental procedures were carried out in compliance with National 
Institutes of Health guidelines and were approved by the Institutional 
Animal Care and Use Committee (Marquette University). 
Catheter implantation 
For intravenous self–administration and reinstatement testing, 
each rat was anesthetized with ketamine HCl (100 mg/kg, i.p.) and 
xylazine (2 mg/kg, i.p.) and had an indwelling silicon (Silastic; Dow 
Corning; 0.64 mm i.d.; 1.19 mm o.d.) catheter implanted into the 
jugular vein. Catheters were connected to back mount cannulae 
(Plastics One) attached to monofilament surgical mesh (Atrium 
Medical). When placed in the operant chambers, the back mount 
cannulae was connected to PE tubing (0.51 mm i.d. × 1.52 mm o.d.) 
encased in stainless-steel spring leashes (Plastics One). The PE tubing 
was connected via a fluid swivel (Instech Lab) suspended above the 
self–administration chamber and Tygon tubing (VWR; 0.51 mm i.d. × 
1.52 mm o.d.) to syringes in pumps (Razel) outside of the operant 
chamber. Rats received ibuprofen in their drinking water for 3 days 
following surgery and were given iv antibiotic treatment for at least 5 
days. The rats were allowed to recover for 1 week before the initiation 
of self–administration training. 
Cocaine Self-Administration 
Self-administration/reinstatement procedures were conducted in 
computer-interfaced operant conditioning chambers equipped with 
retractable levers and stimulus lights above each lever in sound-
attenuating cubicles (MED-Associates). Following recovery from 
surgery, rats were trained to self-administer cocaine (0.5 
mg/kg/infusion) by pressing a lever under a fixed-ratio (FR) 1 
schedule during daily 2-h sessions. Pressing the lever resulted in an 
infusion (200 μL over 5 s) followed by a 10 s time-out period during 
which lever presses were recorded but not reinforced and the stimulus 
light above the lever was extinguished. Responding on a second lever, 
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the inactive lever, was also recorded, but not reinforced. Following 
stable responding, the FR value was increased gradually to FR4. Once 
stable responding on FR4 was achieved (<10% change over 3 days), 
rats were allowed to self-administer cocaine daily for 14 additional 
days. 
Extinction and reinstatement 
After 14 days of cocaine self-administration, rats underwent 
extinction training which was identical to cocaine self-administration 
with the exception that the cocaine was replaced with saline. Rats 
underwent daily 2-h extinction training sessions until they met the 
extinction criterion (<15 lever presses/2 h). Once rats met this 
criterion, a reinstatement test was given the next day. Aside from 
footshock and/or cocaine pre-exposure, reinstatement sessions were 
otherwise identical to extinction conditions. All rats underwent multiple 
reinstatement tests within each experiment in a counterbalanced 
fashion. Each rat received a maximum of 4 reinstatement tests. Rats 
were given additional extinction/washout sessions between 
reinstatement tests until they reached criterion (<15 lever presses/2 
h) before receiving additional reinstatement tests. 
Experiment 1: Effect of CB1R antagonism on stress-
potentiated reinstatement of cocaine seeking  
Under the self–administration parameters used in the present 
study (0.5 mg/kg/inf; 14 × 2 hrs/day), we have found previously that 
footshock alone does not trigger reinstatement of extinguished cocaine 
seeking, but potentiates reinstatement in response to an injection of 
an otherwise subthreshold dose of cocaine (2.5 mg/kg, i.p.; Graf et al. 
2013). Following self-administration and extinction, all rats were 
tested for reinstatement under each of the following conditions, in 
counter-balanced sequence: 1) no footshock/cocaine; 2) 
footshock/saline; and 3) footshock/cocaine following 30-min 
pretreatment with the CB1R antagonist, AM251 (1 or 3 mg/kg, i.p.), or 
vehicle (1:1:18 ethanol: Cremaphor: saline). Separate sets of rats 
were used for each dose of AM251 so each rat received 4 
reinstatement tests total. Intermittent electric footshock (3 × 0.5 mA, 
200 ms duration, mean intershock interval 40s, range 10–70s over a 
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15 min period) was delivered through the stainless-steel grid floors of 
the operant conditioning chambers immediately prior to cocaine (2.5 
mg/kg, i.p.) or saline (0.9% NaCl) injections followed by the 2-h 
reinstatement test sessions. 
Experiment 2: Effect of CB1R antagonism on cocaine-
primed and stress-triggered reinstatement of cocaine 
seeking  
We have previously reported that stress-potentiated 
reinstatement is mediated in part by a mechanism that is distinct from 
that involved in either stress-triggered or cocaine-primed 
reinstatement; stress-potentiated reinstatement is corticosterone-
dependent (Graf et al. 2013), while stress-triggered and cocaine-
primed reinstatement are not (Erb et al. 1998; Graf et al. 2011; 
Mantsch et al., 2008b). To determine if CB1R involvement is also 
selective for stress-potentiated cocaine seeking, we tested separate 
groups of rats for the effects of AM251 on cocaine-primed and stress-
triggered reinstatement. 
To test for the effect of AM251 on cocaine-primed 
reinstatement, rats underwent cocaine self-administration and 
extinction as described above, but were given a systemic injection of a 
dose of cocaine (10 mg/kg, i.p) which has been reported to reliably 
reinstate cocaine seeking (Mantsch et al. 2008b; Mantsch and Goeders 
1999; Mantsch et al. 2004), or saline immediately prior to the start of 
the 2-h reinstatement session. As above, rats were pretreated with 
AM251 (1, 3 mg/kg, ip) or vehicle (1:1:18 ethanol: Cremaphor: 
saline) 30 min prior to the start of the reinstatement test. Each rat 
was tested for reinstatement under each of the following conditions in 
counterbalanced condition: 1) vehicle/saline; 2) vehicle/cocaine; 3) 
AM251/cocaine. Rats were given extinction/washout sessions between 
reinstatement tests until they reached criterion (<15 lever presses/2 
h) before receiving additional reinstatement tests. Each rat received all 
reinstatement tests in a counterbalanced order and received a total of 
3 reinstatement tests. 
To determine if CB1R activation represents a distinct mechanism 
that underlies the ability of stress to potentiate, rather than directly 
trigger induce reinstatement, we tested a separate group of rats for 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg 
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin 
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Springer-Verlag Berlin Heidelberg. 
8 
 
the effect of AM251 under conditions in which footshock stress alone 
can trigger reinstatement of extinguished cocaine seeking. We have 
previously shown that delivery of footshock alone produces reliable 
and robust reinstatement of cocaine seeking in rats with a history of 
longer daily access to cocaine self-administration (6 hrs/day; Mantsch 
et al. 2008a; Blacktop et al. 2011; Vranjkovic et al. 2014). In these 
experiments, rats were provided with daily long access (6 hr/day × 14 
days) to cocaine (0.5 mg/kg/inf) for self-administration prior to 
extinction (as described above) and testing for footshock stress-
triggered reinstatement (same footshock conditions as above). To test 
for CB1R involvement in stress-triggered reinstatement, rats were 
pretreated with either AM251 (1 mg/kg, ip) or vehicle (1:1:18 ethanol: 
Cremaphor: saline) 30 min prior to delivery of footshock followed by 
reinstatement testing. Each rat was tested under the following 
reinstatement conditions, in a counterbalanced order: 1) vehicle/no 
footshock; 2) vehicle/footshock; 3) AM251/no footshock; 4) 
AM251/footshock. Rats were given extinction/washout sessions 
between reinstatement tests until they reached criterion (<15 lever 
presses/2 h) before receiving additional reinstatement tests. Each rat 
received a total of 4 reinstatement tests and was required to once 
again meet the extinction criterion (<15 lever presses/2h) between 
tests. 
Experiment 3: Effect of CB1R antagonism on responding 
for food and basal locomotor activity  
Although the lack of AM251 effects on cocaine-primed and 
stress-triggered reinstatement suggests that the effects of the drug on 
stress-potentiated reinstatement were not secondary to non-specific 
motor suppression, we decided to further address this possibility by 
testing a separate group of rats for AM251 effects on food-reinforced 
responding and locomotor activity. When testing for effects on food-
reinforced behavior, rats were food deprived to 90% of their starting 
body weight and trained to press a lever under a FR4 schedule of 
sucrose-sweetened food pellet (45 mg; BioServ) reinforcement during 
daily 30-min sessions. Drug effects were tested once stable responding 
was achieved (<10% change over 3 days). AM251 (1, 3 mg/kg, ip) or 
vehicle (1:1:18 ethanol: Cremaphor: saline) was administered 30 min 
prior to the start of the session. Each rat received vehicle and both 
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doses of AM251 in a counterbalanced order for a total of 3 tests. Rats 
were given additional days between drug tests to ensure that stable 
food responding was once again achieved before the next test. 
As there is strong evidence for a role of endocannabinoids in 
feeding, metabolism, and obesity (Bellocchio et al. 2006; Kirkham and 
Tucci 2006; Silvestri and Di Marzo 2013), food responding alone may 
not be the most accurate measurement of CB1R antagonist effects on 
motor activity. Therefore, the effect of AM251 on basal locomotor 
behavior was also determined. Locomotor activity was measured in the 
home cages of the rats using an automated activity system (AccuScan 
Instruments, Inc., Columbus, OH) consisting of photocell-containing 
frames, equipped with sensor panels containing 16 photo beams in a 
horizontal orientation, into which cages could be placed for recording. 
Both total (total photobeam breaks) and ambulatory (consecutive 
photobeam) breaks activity counts were recorded using a computer 
interfaced MicroMax software-based system (AccuScan Instruments). 
Prior to testing for drug effects, rats received 3 days of systemic i.p. 
saline injections to habituate them to injections and limit the 
contribution of novelty/injection stress-related effects. Thereafter, all 
rats were tested for effects of AM251 (1 and 3 mg/kg, ip) and vehicle 
(1:1:18 ethanol: Cremaphor: saline) in a counterbalanced sequence 
with washout days between each test. Locomotor activity was 
recorded for one hour starting immediately post-injection. 
Experiment 4: Effect of footshock stress on 
endocannabinoid content in the medial prefrontal cortex  
The medial prefrontal cortex (mPFC) is critical for cocaine 
seeking in response to multiple reinstating stimuli, including footshock 
and cocaine (McFarland et al. 2004). Subregions of the mPFC (e.g., 
prelimbic, infralimbic cortices, anterior cingulate) appear to have 
differential roles in reinstatement following exposure to stress 
(Capriles et al. 2003) or cocaine (Capriles et al. 2003; Peters et al. 
2008). While it has been reported that stress can increase 
endocannabinoid content in the mPFC (Hill et al. 2011), most studies 
examining the effect of stress on eCB content have utilized acute 
restraint or forced swim as stressors (Hill et al. 2011; McLaughlin et al. 
2012; Rademacher et al. 2008; Roberts et al. 2012). We conducted a 
preliminary analysis of the effects of footshock stress on eCB content 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Psychopharmacology, Vol 233, No. 1 (January 2016): pg. 99-109. DOI. This article is © Springer-Verlag Berlin Heidelberg 
and permission has been granted for this version to appear in e-Publications@Marquette. Springer-Verlag Berlin 
Heidelberg does not grant permission for this article to be further copied/distributed or hosted elsewhere without the 
express permission from Springer-Verlag Berlin Heidelberg. 
10 
 
in subregions of the mPFC in rats with no history of cocaine self-
administration. Rats were handled for 2 min/day for 3 days prior to 
exposure to the footshock. On the day of testing, rats were 
transported to the experimental room 1-h prior to administration of 
footshock stress. Rats were placed into the operant conditioning 
chambers and received the same 15-min footshock stress that was 
administered during reinstatement testing: control rats were placed in 
the operant chambers for 15 min but did not receive the stressor. 
Immediately after the 15-min footshock session, rats were placed back 
into their home cages and 15 min later were rapidly decapitated under 
isoflurane anesthesia (30-s exposure) for tissue collection. Brains were 
rapidly removed (2.5 min total time) and flash frozen by submersion in 
liquid nitrogen for 25s and then stored at −80°C. 
For tissue dissection, 1 mm prefrontal cortical sections (approx. 
3.72 mm to −2.76 mm from Bregma) were isolated from coronal 
sections on dry ice. Prefrontal cortical subregions (prelimbic (PL), 
infralimbic (IL), and anterior cingulate cortices (AC)) were dissected 
bilaterally using a scalpel blade, weighed and collected in a 
microcentrifuge tube and stored at −80°C. Subregions from two 
animals were pooled for each data point. 
Endocannabinoid Liquid Chromatography/Mass 
Spectrometry 
Concentrations of the endocannabinoids N-
arachidonylethanolamine (AEA) and 2-arachidonylglycerol (2-AG) were 
extracted from tissue using a protocol adapted from Patel et al. 2003. 
Briefly, tissue samples were homogenized in 2mL of acetonitrile with 
84 pmol [2H8]AEA and 186pmol [2H8]2-AG using glass rods. Samples 
were sonicated for 60 min and frozen overnight at −20°C to 
precipitate proteins. The supernatant was obtained following 
centrifugation at 1500 × g for 2 min at 4°C, was dried under N2 and 
the lipids were resuspended in methanol. The two endocannabinoids 
were isolated and quantified by liquid chromatography-electrospray 
ionization-mass spectrometry (LC-ESI-MS; Agilent LC-MSD 1100 
series) and quantified by isotope dilution as described previously (Patel 
et al. 2003). 
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Drugs 
Cocaine HCl was obtained from the National Institute on Drug 
Abuse (NIDA) through the NIDA Drug Supply Program. The CB1R 
antagonist AM251 was purchased from Sigma-Aldrich. Cocaine was 
dissolved in saline (0.9% bacteriostatic saline). AM251 was dissolved 
first in ethanol, followed by Cremaphor and finally by saline (0.9% 
bacteriostatic saline) in a 1:1:18 ratio. 
Statistical Analysis 
Statistical analyses were conducted using SPSS statistics 
software and consisted of one- or two-way repeated measures ANOVA 
followed, when appropriate, with post-hoc testing using Bonferroni-
corrected t-tests. For all analyses, statistical significance was defined 
as p<0.05. 
Results 
The numbers of cocaine infusions and responses during the self-
administration and extinction sessions for each reinstatement 
experiment are shown in Table 1. Rats showed consistent responding 
during self-administration between self–administration day 1 and 14 in 
experiments 1 and 2. Following completion of cocaine self-
administration, rats showed a reduction in lever presses across 
extinction sessions in both experiments and took an average of 7.67 ± 
1.38 extinction sessions before reaching criteria. 
Table 1. Cocaine self-administration and extinction responding 
Experiment no. (n) Cocaine SA  
 
Extinction  
 
SA Day 1 SA Day 14 First Ext Last Ext 
1 ShA; (12) 121.4 ± 7.5 126.8 ± 7.8 75.9 ± 7.2 9.9 ± 1.0 
2 ShA; (8) 117.3 ± 10.6 120.0 ± 11.0 77.4 ± 19.3 9.1 ± 1.8 
 LgA; (5) 317.8 ± 34.2 396.0 ± 12.54 166.8 ± 41.2 7.6 ± 2.6 
Data represent total active lever responses/2-h session ± SEM for experiments 1 and 
2 for short access (ShA) experiments, and lever responses/6-hr session ± SEM for 
experiment 2 for long-access (LgA) experiments during days 1 and 14 of cocaine self-
administration (SA) and total active lever responses/2-h session ± SEM on the first 
day of extinction (Ext) and the last day of extinction before reinstatement testing for 
experiments 1 and 2. 
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Experiment 1: Effect of CB1R antagonism on 
stress-potentiated reinstatement of cocaine 
seeking 
To confirm that stress produced a potentiation of cocaine-
induced reinstatement, as previously described (Graf et al. 2013) we 
initially compared reinstatement following administration of the 
footshock/cocaine combination with reinstatement following 
footshock/saline or administration of cocaine alone (no 
footshock/cocaine) only in rats pretreated with the vehicle for AM251 
(1:1:18 ethanol: Cremaphor: saline). As previously reported in rats 
tested under the same self-administration conditions (Graf et al. 
2013), neither low-dose cocaine (2.5 mg/kg, i.p.) nor footshock alone 
reinstated cocaine seeking. However, robust reinstatement was 
observed when the two stimuli were combined (Fig. 1). A two-way 
repeated measures ANOVA showed significant main effects of 
reinstatement testing (extinction vs. reinstatement; F(1,22)=45.26, 
p<0.001) and reinstatement condition (footshock/saline, no 
footshock/cocaine, footshock/cocaine; F(2,22)=24.42, p<0.001) and a 
significant interaction between the reinstatement day and 
reinstatement condition (F(2,22)=25.52, p<0.001). Post-hoc testing 
revealed significant reinstatement (compared to extinction responses) 
following delivery of the footshock/cocaine combination (p<0.001) but 
not with footshock/saline or cocaine alone. Moreover, while no 
differences in extinction responding were observed across treatment 
conditions, responding during the reinstatement session that followed 
delivery of the footshock/cocaine was increased compared to 
responding following footshock/saline or cocaine alone (p<0.001). 
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Figure 1. Stress-potentiated reinstatement is CB1R-dependent. Data represent mean 
active lever responses (± SEM) during 2-h extinction and reinstatement tests. Stress-
potentiated reinstatement is observed when rats are exposed to a stressor, 15 min 
intermittent electric footshock stress (EFS) followed immediately by a subthreshold 
dose of cocaine (COC, 2.5 mg/kg, i.p.; **p<.01, compared to reinstatement). Stress-
potentiated reinstatement is blocked by pre-treatment with the CB1R antagonist 
AM251 (1 (n=6), 3 (n=6) mg/kg, i.p.) 30 min prior to the reinstatement test (#p<.05 
compared to Veh/EFS/COC). 
The effects of 1 mg/kg AM251 and vehicle (Veh) and 3 mg/kg 
AM251 and vehicle were assessed in different groups of rats, so a 
separate 2-way repeated measures (footshock/cocaine x AM251 
pretreatment) ANOVA was conducted for each dose. Both doses of 
AM251 prevented stress-potentiated reinstatement. For 1 mg/kg 
AM251 doses, 2-way repeated measures ANOVA showed an overall 
significant effect of reinstatement (Extinction vs. Reinstatement; 1 
mg/kg: F(1,5)=26.86, p<0.01), but not drug (Veh vs. AM251; 
F(1,5)=5.03, p=0.08) and a significant interaction between the 
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reinstatement day and drug (F(1,5)=9.74, p<0.05). Post-hoc testing 
showed that reinstatement was observed in Veh-pretreated (p <0.05), 
but not AM251 pretreated rats and that reinstatement following vehicle 
pretreatment was significantly increased relative to reinstatement 
following AM251 (p<0.05). Similarly, for the 3 mg/kg AM251 dose, 2-
way repeated measures ANOVA revealed significant overall effects of 
reinstatement testing (F(1,5)=14.02, p<0.05) and AM251 
pretreatment (F(1,5)=12.18, p<0.05) and a significant reinstatement 
x pretreatment interaction (F(1,5)=18.24, p<0.01). As with the lower 
dose, post-hoc testing demonstrated that reinstatement was observed 
in Veh-pretreated rats (p <0.05), but not rats pretreated with 3 mg/kg 
AM251 and that reinstatement following vehicle pretreatment was 
significantly increased relative to reinstatement following 3 mg/kg 
AM251 (p<0.05). 
Experiment 2: Effect of CB1R antagonism on 
cocaine-primed and stress-triggered 
reinstatement of cocaine seeking 
In contrast to stress-potentiated cocaine-induced reinstatement, 
AM251 did not prevent reinstatement in response to a 10 mg/kg i.p. 
priming dose of cocaine (Fig. 2A). Effects of pretreatment with 1 
mg/kg and 3 mg/kg AM251 on cocaine-primed reinstatement were 
tested in separate groups of rats. In both cases 2-way repeated 
measures reinstatement (reinstatement vs. extinction) x drug 
pretreatment (AM251 vs. Veh) ANOVA revealed overall reinstatement 
effects (F(1,7)=18.62, p<0.001 and F(1,7)=25.51, p<0.01) but not 
overall effects of AM251 and no reinstatement x AM251 pretreatment 
interactions. 
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Figure 2. Cocaine-primed or stress-induced reinstatement is not CB1R-dependent. 
Data represent mean active lever responses (± SEM) during 2-h extinction and 
reinstatement tests. A. Cocaine-primed reinstatement is observed when rats are given 
a systemic injection of a high dose of cocaine (COC, 10 mg/kg, i.p.; **p<.01 
compared to extinction). Cocaine-primed reinstatement is not significantly attenuated 
by pre-treatment with the CB1R antagonist, AM251 (1 (n=8), 3 (n=8) mg/kg, i.p.) 30 
min prior to the cocaine injection. B. Stress-induced reinstatement is observed when 
rats are given electric footshock stress (EFS) for 15 min immediately followed by the 
reinstatement session in rats with a history of long-access self-administration 
(**p<.01 compared to extinction). Stress-induced reinstatement is not significantly 
attenuated by pretreatment with AM251 (1 mg/kg, i.p.; n=5) 30 min prior to EFS. 
While stress-potentiated reinstatement in short-access rats was 
blocked by pretreatment with AM251 (1 mg/kg, ip), stress-triggered 
reinstatement in long-access rats was unaffected by the same 
treatment (Fig 2B). A 2-way repeated measures drug pretreatment 
(Veh vs AM251) x reinstatement (no footshock vs footshock) ANOVA 
revealed overall reinstatement effects (F(1,4)=37.16, p<0.01) but no 
overall effects of AM251 and no reinstatement x AM251 pretreatment 
interactions. Post-hoc testing demonstrated that reinstatement was 
observed in both Veh- (p <0.01), and AM251-pretreated rats (p<0.01) 
but that reinstatement following vehicle pretreatment was not 
significantly different from reinstatement following 1 mg/kg AM251 
(p>0.05). 
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Experiment 3: Effect of CB1R antagonism on 
responding for food and basal locomotor activity 
AM251 at a dose of 3 mg/kg produced dose-dependent 
reductions in food-reinforced lever pressing while 1 mg/kg AM251 was 
without significant effect (Fig. 3). A one-way repeated measures 
ANOVA revealed a significant AM251 effect on food-reinforced 
responding (Veh, 1 mg/kg AM251, 3 mg/kg AM251; F(2,12)=4.41, 
p<0.05) and post hoc testing demonstrated that pretreatment with 3 
mg/kg, but not 1 mg/kg AM251 significantly attenuated food-
reinforced lever responding compared to vehicle pretreatment 
(p<0.05). 
 
Figure 3. Food-reinforced lever pressing is attenuated by pre-treatment with the 
CB1R antagonist AM251. Data are presented as mean food lever responses during the 
30-min session ± SEM. Pre-treatment with AM251 30 min prior to the beginning of the 
session significantly attenuated food-reinforced lever pressing at the higher dose (3 
mg/kg, i.p), but not the low dose (1 mg/kg, i.p.; n=7; *p<.05 compared to Veh). 
Each rat received each drug treatment and the order of drug treatment was 
counterbalanced. 
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AM251 effects on basal locomotor activity were tested (Table 2). 
A one-way repeated measures ANOVA did not reveal a significant 
effect of the drug (Veh, 1 mg/kg AM251, 3 mg/kg AM251) for either 
total activity (F(2,10)=2.56, p=0.13) or ambulatory movement 
(F(2,10)=0.81, p=0.47) consistent with previous findings (Adamczyk et 
al. 2012). 
Table 2. Effects of CB1R antagonism on locomotor activity 
 
1st 30 min  
 
2nd 30 min  
 
Total 1 hr  
 
Total Ambulatory Total Ambulatory Total Ambulatory 
Vehicle 1632 ± 
286 
701 ± 122 611 ± 138 301 ± 64 2244 ± 
249 
1003 ± 122 
AM251 
(1) 
1539 ± 
280 
681 ± 104 854 ± 231 323 ± 75 2393 ± 
435 
1005 ± 149 
AM251 
(3) 
2058 ± 
283 
776 ± 114 1391 ± 
257 
484 ± 70 3450 ± 
477 
1261 ± 163 
Data represented are mean activity counts ± SEM for total (total beam breaks) and 
ambulatory (consecutive beam breaks) activity. The data are presented as activity 
during the 1st 30 min, 2nd 30 min, and total 1-h after the injection of either Vehicle 
(1:1:18 ethanol: Cremaphor: saline) or AM251 (1, 3 mg/kg, i.p.). Systemic 
administration of AM251 did not significantly affect total or ambulatory activity (n=6) 
during the 1-h after the injection. 
Experiment 4: Effect of footshock stress on 
endocannabinoid content in the medial prefrontal 
cortex 
The effects of footshock stress on contents of AEA and 2-AG in 
subregions of the medial prefrontal cortex were examined in drug-
naïve rats euthanized 15 min after the footshock period ended (Table 
3). A 2-way ANOVA with footshock and brain region as factors 
revealed an overall significant effect of footshock on AEA content 
(F(1,36)=8.411 p<.01) and an overall effect of brain region (F(1,36) = 
18.10, p<.001) on 2-AG content. We also ran planned comparisons in 
each region for the effect of stress on AEA or 2-AG in each region. 
Despite trends in each region AEA was not significantly increased in 
any brain region (PL: p=0.10; IL: p=0.12; AC: p=0.20) but 2-AG 
content was significantly increased in the AC as a result of stress 
(p<.05). 
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Table 3. Effects of footshock stress on endocannabinoid content in 
subregions of the medial prefrontal cortex 
 
2-AG (nmol/g tissue) AEA (pmol/g tissue) 
Control Shock Control Shock 
Anterior Cingulate 2.4 ± 0.6 5.6 ± 0.5 8.9 ± 0.9 19.3 ± 5.1 
Prelimbic 11.0 ± 1.8 9.6 ± 1.5 7.1 ± 2.7 17.8 ± 5.4 
Infralimbic 4.6 ± 0.7 5.5 ± 0.8 6.3 ± 1.0 16.8 ± 7.1 
Data represented are mean concentrations of the endocannabinoids 2-
arachidonylglycerol (2-AG; nmol/g tissue) and anandamide (AEA; pmol/g tissue) 15 
min after termination of a 15 min-footshock (n=7) or in control rats (n=7). There was 
a significant effect of footshock stress on AEA levels across the 3 brain regions 
(p<.001). Footshock stress significantly increased 2-AG in the anterior cingulate 
cortex (p<.05) and levels of 2-AG in the prelimbic cortex are significantly higher than 
those in the anterior cingulate or infralimbic (p<.001). 
Discussion 
Under conditions where it does not directly trigger relapse, 
stress can promote responsiveness to other stimuli, thereby “setting 
the stage” for drug use. We have previously modeled this stage-
setting effect using a self-administration/approach in which footshock 
stress augments cocaine-induced reinstatement in rats (Graf et al. 
2013). We reproduced these findings in the present study, 
demonstrating that, under the self–administration parameters used 
(0.5 mg/kg/inf; 14 × 2 hrs/day), footshock alone does not reinstate 
cocaine seeking, but potentiates reinstatement in response to an 
injection of an otherwise subthreshold dose of cocaine (2.5 mg/kg, 
i.p.). We demonstrate that this stage-setting effect of stress is 
dependent on CB1R signaling. In our paradigm, systemic 
administration of the CB1R antagonist, AM251, prevents stress-
potentiated reinstatement but does not affect reinstatement in 
response to a priming dose of cocaine (10 mg/kg, ip) or alter 
reinstatement triggered by shock alone in rats with a history of 
cocaine self-administration under long-access (daily 6-h/day) 
conditions. Moreover, although AM251 also attenuated food-reinforced 
lever pressing, reductions in reinstatement were observed at an 
AM251 dose that did not alter food-reinforced responding, while 
reductions in locomotor activity were not observed at any dose tested. 
Endocannabinoid signaling in the brain is stress-responsive and 
is necessary for stress adaptation and coping (Hill et al. 2011; 
McLaughlin et al. 2012; McLaughlin et al. 2013; McLaughlin et al. 
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2014). There are two subtypes of cannabinoid receptors: CB1 and 
CB2. The CB1 receptor is considered to be the predominant 
cannabinoid receptor in the brain and is expressed in regions critical 
for motivated behavior, including the prefrontal cortex, nucleus 
accumbens, and the ventral tegmental area (Devane et al. 1988; 
Egertova et al. 1998; Herkenham et al. 1991; Melis et al. 2004; Pettit 
et al. 1998; Wenger et al. 2003), thus positioning CB1Rs as regulators 
of behavioral processes that enable organisms to effectively respond to 
stressors and as potential mediators through which stress can 
influence drug-seeking behavior. Our finding that AM251 prevented 
the potentiating effects of stress on cocaine-induced reinstatement is 
consistent with this role for CB1Rs. Moreover, the finding that AM251 
did not alter either cocaine-primed or stress-triggered reinstatement in 
this model suggests that while CB1Rs are important for the interaction 
between stress and cocaine, they may be less important for the 
response to either stimuli by itself. 
Our study is not the first to examine the contribution of CB1Rs 
to the reinstatement of extinguished cocaine seeking. De Vries et al. 
(2001) reported that the CB1R agonist, HU210, reinstated cocaine 
seeking, while the CB1R antagonist, rimonabant, attenuated cocaine-
primed and cue-induced reinstatement but not stress-triggered 
reinstatement in male Wistar and Long Evans rats. These effects on 
cocaine-primed reinstatement were reproduced by Xi et al. (2006) and 
Adamcyzk et al. (2012) using AM251. It is possible that experimental 
differences, such as rat strains employed (our study is the only one 
using Sprague Dawley rats), route of administration for the cocaine-
prime injection, self-administration parameters, or CB1R antagonist 
pretreatment times and doses underlie the different responses 
obtained. However, we are not the first to report as others have also 
reported a lack of effect of CB1R antagonism on cocaine-primed 
reinstatement. Another study did report attenuation of cocaine-primed 
reinstatement by AM251 (Filip et al. 2006), but the AM251 dose at 
which effects were observed in that study (10 mg/kg, ip) was very 
high and effects within the AM251 dose range used in the present 
study were not found. Moreover, Kupferschmidt et al. (2012) found 
that icv administration of AM251 blocked CRF-induced reinstatement 
but failed to block footshock- or cocaine-primed reinstatement. In 
addition, studies using mice have found no effect of CB1R antagonism 
on cocaine-primed reinstatement following cocaine self-administration 
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(Ward et al. 2009) or cocaine-conditioned place preference (Vaughn et 
al. 2011). Clarification of the precise conditions under which CB1Rs do 
and do not contribute to cocaine-primed reinstatement will require 
further investigation. Notably, CB1R antagonists or negative allosteric 
modulators have also been reported to inhibit on drug-primed heroin 
(De Vries et al. 2003; Fattore et al. 2005) and methamphetamine 
(Jing et al. 2014) reinstatement as well cue-induced reinstatement 
following alcohol (de Bruin et al. 2011), heroin (De Vries et al. 2003), 
methamphetamine (Jing et al. 2014) and nicotine (De Vries et al. 
2005) self-administration. In contrast to our findings, these results 
suggest that the involvement of CB1Rs in drug seeking may extend 
beyond the potentiating effects of stress. 
Our finding that AM251 fails to block stress-triggered 
reinstatement is consistent with studies by De Vries et al. (2001) and 
Kupferschmidt et al. (2012). We previously reported that the 
mechanisms responsible for stress-triggered reinstatement and those 
that mediate stress-potentiated reinstatement are distinct. For 
example, eliminating the corticosterone response to stress has no 
effect on stress-triggered reinstatement of extinguished cocaine 
seeking (Erb et al. 1998; Graf et al. 2011), but prevents the ability of 
stress to potentiate low-dose cocaine-induced reinstatement (Graf et 
al. 2013). Similar to corticosterone, we observe that the CB1R 
antagonist AM251 blocked stress-potentiated reinstatement, but not 
cocaine-primed or stress-triggered reinstatement, suggesting that 
endocannabinoid involvement in cocaine-seeking behavior in these 
conditions is also more important for the interaction between stress 
and cocaine than either stimuli alone. This parallel between 
corticosterone and endocannabinoids is interesting, considering that 
corticosterone has been reported to regulate endocannabinoid 
contents in brain regions that have been implicated in cocaine-seeking 
behavior (Hill et al. 2011; Kalivas and McFarland 2003; McFarland et 
al. 2004; Rademacher et al. 2008). For example, restraint stress 
produces glucocorticoid-dependent increases in the endocannabinoid, 
2-AG, in the prelimbic cortex, resulting in a CB1R-dependent 
attenuation of GABAergic neurotransmission that disinhibits pyramidal 
neuron outputs (Hill et al. 2011) that likely include a key glutamatergic 
pathway to the nucleus accumbens core that has been implicated in 
cocaine-seeking behavior (McFarland et al. 2004). 
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In the present study, we observed that footshock stress 
increased AEA contents in PL, IL and AC subregions of the medial 
prefrontal cortex and increased 2-AG content in the AC. These results 
are consistent with prior studies indicating that the prefrontal cortical 
endocannabinoid system is modulated by stress and anxiety conditions 
(Hill et al. 2011; McLaughlin et al. 2012; Morena et al. 2014; 
Rademacher et al. 2008; Roberts et al. 2012). However, prefrontal 
cortical responses vary in response to different stressors, whereby AEA 
is decreased following acute restraint (Hill et al. 2011) and swim stress 
(McLaughlin et al. 2012), or chronic restraint stress (Rademacher et al. 
2008), but is increased following a single footshock (Morena et al. 
2014), and 2-AG is increased after acute (Hill et al. 2011) or chronic 
restraint stress (Rademacher et al. 2008). While most stressors result 
in decreased AEA, footshock stress appears unique in eliciting 
increases in AEA in periaqueductal grey (Hohmann et al. 2005), 
basolateral amygdala, and dorsal hippocampus (Morena et al. 2014). 
While it is not presently clear why footshock stress produces unique 
AEA responses, it is possible that that this increase is observed in part 
as a consequence of pain mechanisms. These data support a role for 
footshock stress-induced increases in endocannabinoid content in 
relevant brain regions though these levels were not examined in rats 
with a history of cocaine self-administration or under reinstating 
conditions. 
Several pieces of evidence indicate that the effects of AM251 to 
reduce stress-potentiated reinstatement are not the result of non-
specific motor effects. However to fully examine that possibility, we 
initially assessed the effects of AM251 on food-reinforced lever 
pressing. AM251 dose-dependently suppressed food-reinforced 
responding. However, while the higher AM251 dose tested (3 mg/kg) 
reduced both reinstatement and food-reinforced responding, the lower 
AM251 dose (1 mg/kg) selectively attenuated stress-potentiated 
reinstatement. These findings are consistent with prior reports showing 
significantly lower food-reinforced responding when pre-treated with 3 
mg/kg but not 1 mg/kg (Adamczyk et al. 2012). Notably, there is 
strong evidence for endocannabinoid involvement in feeding, 
metabolism and obesity (Bellocchio et al. 2006; Kirkham and Tucci 
2006; Silvestri and Di Marzo 2013), suggesting that the attenuation of 
food-reinforced responding represents an effect on appetite, and not a 
motor effect. Consistent with this possibility, AM251 did not attenuate 
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cocaine-primed or shock-triggered reinstatement. In order to further 
assess any potential non-specific motor effects of AM251, we also 
tested rats for effects of AM251 on locomotor activity. Pre-treatment 
with AM251 had no significant effect on locomotor activity at either 
dose, which is also consistent with earlier reports (Adamczyk et al. 
2012), suggesting that AM251 effects on reinstatement behavior were 
not the result of non-specific motor suppression. In fact, there was a 
trend towards increased locomotor activity at the higher AM251 dose. 
Taken altogether, our findings suggest that endocannabinoid 
involvement in stress-potentiated reinstatement is specific to the 
ability of stress to potentiate the responsiveness to subthreshold 
reinstating stimuli. 
The present findings add to a large body of research implicating 
endocannabinoid signaling in cocaine addiction (see Wiskerke et al. 
2008 for review). Notably, polymorphisms of the gene for the CB1 
receptor, CNR1, are associated with cocaine dependence (Clarke et al. 
2013; Lopez-Moreno et al. 2012; Zuo et al. 2007; Zuo et al. 2009) 
and it has been suggested that circulating endocannabinoids may be a 
viable biomarker for cocaine use disorder in humans (Pavon et al. 
2013). Demonstration of a contribution of endocannabinoid signaling 
to cocaine use in the context of stress may shed additional light on the 
complex relationship between endocannabinoids and cocaine addiction. 
While issues related to psychiatric side effects may limit the clinical 
utility of CB1R antagonists (Christensen et al. 2007), at minimum 
these data provide mechanistic insight into the processes through 
which stress influences drug relapse and therefore may guide future 
treatment approaches. 
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